Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Open accessThe DOI matches its Crossref record; 235 of the 237 references it cites were found in a registry or an index.
Abstract
NADPH oxidases are a family of enzymes that generate reactive oxygen species (ROS). The NOX1 (NADPH oxidase 1) and NOX2 oxidases are the major sources of ROS in the artery wall in conditions such as hypertension, hypercholesterolaemia, diabetes and ageing, and so they are important contributors to the oxidative stress, endothelial dysfunction and vascular inflammation that underlies arterial remodelling and atherogenesis. In this Review, we advance the concept that compared to the use of conventional antioxidants, inhibiting NOX1 and NOX2 oxidases is a superior approach for combating oxidative stress. We briefly describe some common and emerging putative NADPH oxidase inhibitors. In addition, we highlight the crucial role of the NADPH oxidase regulatory subunit, p47phox, in the activity of vascular NOX1 and NOX2 oxidases, and suggest how a better understanding of its specific molecular interactions may enable the development of novel isoform-selective drugs to prevent or treat cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The current knowledge about NOX enzymes in the cardiovascular system indicates that NOX2 is usually the main player in the development of pathological conditions and increased NOX2 activity is linked to vascular disease (142, 252, 478).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
The cited source says what the claim attributes to it.
In the citing paper
“In the human vasculature, the most relevant isoforms appear to be NOX1, NOX2, NOX4, and NOX5 (252, 253, 555).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
In the citing paper
“NADPH oxidase, a multiunit enzyme particularly enriched in cerebral blood vessels (Miller et al., 2005), has emerges as an important source in vascular oxidative stress in aging, hypertension, hyperlipidemia and diabetes (Faraci, 2011), and inhibition or genetic inactivation of this enzyme has been shown to ameliorate the vascular dysfunction (Drummond et al., 2011).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Drummond et al., 2011
In the citing paper
“NOXs are multiprotein enzyme complexes that catalyze the electron transfer to molecular oxygen to form ROS, more commonly superoxide, but also hydrogen peroxide (79, 252, 383, 546, 912).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
In the citing paper
“The current knowledge about NOX enzymes in the cardiovascular system indicates that NOX2 is usually the main player in the development of pathological conditions and increased NOX2 activity is linked to vascular disease (142, 252, 478).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989 · cited 1×
“As vascular NADPH oxidases, especially NOX2 oxidase, are similar in structure to the phagocytic NADPH oxidase (see below and Ref”
BackgroundNOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125 · cited 1×
“NOX2 oxidase in phagocytic cells was the first member of the NADPH oxidase family to be identifie”
BackgroundAngiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Self-citationRole of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624 · cited 1×
“Oxidative stress not only causes direct and irreversible oxidative damage to macromolecules but also disrupts key redox-dependent signalling processes in the arterial wal”
BackgroundSuperoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Gryglewski, R. J., Palmer, R. M. J., & Moncada, S. (1986) · Nature · doi:10.1038/320454a0 · Cited by 2,400 · cited 1×
“This nullifies the anti-inflammatory and vasodilator functions of NO, and promotes the formation of peroxynitrit”
BackgroundPeroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134 · cited 1×
“Peroxynitrite is a powerful oxidant in its own right, and may thus contribute to oxidative stress through oxidation of small-molecule antioxidants such as glutathione, cysteine and tetrahydro—biopteri”
BackgroundSegal, A. W. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115653 · Cited by 1,789 · cited 1×
“NOX2 oxidase-expressing leukocytes classically comprise cells of the innate immune system — that is, neutrophils, monocytes and macrophage”
BackgroundRole of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736 · cited 1×
“NOX2 oxidase activity in circulating T lymphocytes is increased in experimental hypertensio”
BackgroundChronic Granulomatous Disease: Report on a National Registry of 368 Patients
Winkelstein, J. A., Marino, M. C., Johnston, R. B., Boyle, J., Curnutte, J., Gallin, J. I., Malech, H. L., Holland, S. M., Ochs, H., Quie, P., et al. (2000) · Medicine · doi:10.1097/00005792-200005000-00003 · Cited by 1,728
Immune and Inflammatory Mechanisms of Atherosclerosis
Galkina, E., & Ley, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,437
Research works printed but not linked: 1
- Takac, I. et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J. Biol. Chem. 286, 13304–13313 (2011). · DOI · Paper page
Cited by
Items 101–200 of 900
The Nox Family of NADPH Oxidases: Friend or Foe of the Vascular System?
Takac, I., Schröder, K., & Brandes, R. P. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0238-3 · Cited by 153
The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: An update
Zhang, H., Dellsperger, K. C., & Zhang, C. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-011-0237-1 · Cited by 144
“[15] for review).”
Oxidative Stress in Aging-Matters of the Heart and Mind
Venkataraman, K., Khurana, S., & Tai, T. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140917897 · Cited by 142
“NAD(P)H oxidase 1 and 2 (NOX1 and 2) are the two major contributors toward ROS generation, with the p47phox subunit being a critical component of the enzyme complex [20].”
BackgroundYahyapour, R., Motevaseli, E., Rezaeyan, A., Abdollahi, H., Farhood, B., Cheki, M., Rezapoor, S., Shabeeb, D., Musa, A. E., Najafi, M., et al. (2018) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1828-6 · Cited by 155
Oxidative stress in chronic vascular disease: From prediction to prevention
Santilli, F., D’Ardes, D., & Davì, G. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.09.003 · Cited by 156
Hernanz, R., Martínez‐Revelles, S., Palacios, R., Martín, Á., Cachofeiro, V., Aguado, A., García-Redondo, L., Barrús, M. T., de Batista, P. R., Briones, A. M., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13117 · Cited by 149
“The mechanisms responsible for the vascular alterations induced by increased ROS production include VSMC proliferation and migration, oxidation of matrix metalloproteinases and generation of matrix proteins such as collagen (Virdis et al., 2004; Briones et al., 2009; Drummond et al., 2011).”
BackgroundAnti-Hypertensive Herbs and Their Mechanisms of Action: Part II
Anwar, M. A., Disi, S. S. A., & Eid, A. H. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00050 · Cited by 162
An update on oxidative stress-mediated organ pathophysiology
Rashid, K., Sinha, K., & Sil, P. C. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.09.026 · Cited by 150
Feng, D., Yang, C., Geurts, A. M., Kurth, T., Liang, M., Lazar, J., Mattson, D. L., O'Connor, P. M., & Cowley, A. W. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.003 · Cited by 137
“Since DPI is recognized as a nonselective inhibitor of all FAD-containing enzymes, including xanthine oxidase, cytochrome p450 oxidoreductase, NADH dehydrogenase, and others (Drummond et al., 2011), the residual O2 .”
BackgroundSeals, D. R., Kaplon, R. E., Gioscia-Ryan, R. A., & LaRocca, T. J. (2014) · Physiology · doi:10.1152/physiol.00059.2013 · Cited by 138
“Prescription pharmaceutical drugs represent the category of pharmacological agents that have been most thoroughly tested for safety and efficacy in humans, usually in the setting of clinical trials on patients with existing clinical CVD or major risk factors for CVD.”
InfluentialNox2 NADPH Oxidase Has a Critical Role in Insulin Resistance–Related Endothelial Cell Dysfunction
Sukumar, P., Viswambharan, H., Imrie, H., Cubbon, R. M., Yuldasheva, N., Gage, M., Galloway, S., Skromna, A., Kandavelu, P., Santos, C. X., et al. (2013) · Diabetes · doi:10.2337/db12-1294 · Cited by 136
“A major source of ROS to emerge over the last decade is NADPH oxidase (Nox) (7,8).”
BackgroundNADPH oxidases and vascular remodeling in cardiovascular diseases
García‐Redondo, A. B., Aguado, A., Briones, A. M., & Salaíces, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.015 · Cited by 146
Marino, A., Hausenloy, D. J., Andreadou, I., Horman, S., Bertrand, L., & Beauloye, C. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.047 · Cited by 148
“given its capability to suppress oxidative stress and control major contributors of ROS - the Nox family [58,59].”
BackgroundNox4 and diabetic nephropathy: With a friend like this, who needs enemies?
Gorin, Y., & Block, K. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.014 · Cited by 134
Natural Compounds as Modulators of NADPH Oxidases
Maraldi, T. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/271602 · Cited by 131
Cerium Oxide Nanoparticles Protect Endothelial Cells from Apoptosis Induced by Oxidative Stress
Chen, S., Hou, Y., Cheng, G., Zhang, C., Wang, S., & Zhang, J. (2013) · Biological Trace Element Research · doi:10.1007/s12011-013-9678-8 · Cited by 131
Oxidative Stress in Cell Death and Cardiovascular Diseases
Xu, T., Ding, W., Ji, X., Ao, X., Liu, Y., Yu, W., & Wang, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9030563 · Cited by 145
“Although the intracellular ROS comes from multiple sources, the activities of NADPH oxidases (NOXs) are the only primary ROS resources (Figure 1) [6, 7].”
BackgroundVong, L. B., Bui, T. Q., Tomita, T., Sakamoto, H., Hiramatsu, Y., & Nagasaki, Y. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.023 · Cited by 132
Huynh, K., Kiriazis, H., Du, X., Love, J. E., Gray, S. P., Jandeleit-Dahm, K. A. M., McMullen, J. R., & Ritchie, R. H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.021 · Cited by 139
Reactive Oxygen Species: Physiological Roles in the Regulation of Vascular Cells
Vara, D. S., & Pula, G. (2014) · Current Molecular Medicine · doi:10.2174/1566524014666140603114010 · Cited by 146
Man, A. W. C., Zhou, Y., Xia, N., & Li, H. (2020) · Nutrients · doi:10.3390/nu12103054 · Cited by 128
“BCAAs trigger ROS formation in peripheral blood mononuclear cells through the activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2) [108], which is particularly important in immune cells [109].”
BackgroundEndothelial Function and Dysfunction: Impact of Metformin
Nafisa, A., Gray, S. G., Cao, Y., Wang, T., Xu, S., Wattoo, F. H., Barras, M., Cohen, N., Kamato, D., & Little, P. J. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.07.007 · Cited by 128
Redox regulation of the actin cytoskeleton and its role in the vascular system
Xu, Q., Huff, L. P., Fujii, M., & Griendling, K. K. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.004 · Cited by 138
“A considerable amount of in vivo evidence suggests that ROS are involved in both hypertension and proatherogenic mechanisms and contribute to vascular dysfunction [368,369].”
Self-citationCatechins: Protective mechanism of antioxidant stress in atherosclerosis
Sheng, Y., Sun, Y., Tang, Y., Yu, Y., Wang, J., Zheng, F., Li, Y., & Sun, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1144878 · Cited by 147
“They can produce superoxide anions via superoxide radical formation and play an important role in the formation of endogenous H2O2 (Bedard and Krause, 2007; Drummond et al., 2011; Sies et al., 2017).”
BackgroundInfluentialGanbaatar, B., Fukuda, D., Shinohara, M., Yagi, S., Kusunose, K., Yamada, H., Soeki, T., Hirata, K.-I., & Sata, M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173040 · Cited by 121
Nox as a target for diabetic complications
Gorin, Y., & Block, K. (2013) · Clinical Science · doi:10.1042/cs20130065 · Cited by 120
Silva, D. V. T. D., Baião, D. D. S., Ferreira, V. F., & Paschoalin, V. M. F. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1822277 · Cited by 118
Endothelial Dysfunction and Amyloid-β-Induced Neurovascular Alterations
Koizumi, K., Wang, G., & Park, L. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0256-9 · Cited by 118
“Initially identified in phagocytes, NADPH oxidase is also found in vascular cells and is especially abundant in the brain blood vessels (Drummond et al. 2011; Miller et al. 2005).”
InfluentialOxidative Stress, Nox Isoforms and Complications of Diabetes—Potential Targets for Novel Therapies
Sedeek, M. H., Montezano, A. C. I., Hébert, R., Gray, S. P., Marco, E. D., Jha, J. C., Cooper, M. E., Jandeleit-Dahm, K. A. M., Schiffrin, E. L., Wilkinson‐Berka, J. L., et al. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9387-2 · Cited by 128
Al-Magableh, M., Kemp‐Harper, B. K., & Hart, J. L. (2014) · Hypertension Research · doi:10.1038/hr.2014.125 · Cited by 122
Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems
Song, P., & Zou, M.-H. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.025 · Cited by 117
Pharmacological Applications of Antioxidants: Lights and Shadows
Saso, L., & Firuzi, O. (2014) · Current Drug Targets · doi:10.2174/1389450115666141024113925 · Cited by 126
“O2 •- can then react with NO producing peroxynitrite (PN), a highly reactive RNS, which can further reduce the level of BH4 [32-34] and directly affect NOS leading to further uncoupling [30].”
BackgroundGuo, S., Yao, Q., Ke, Z., Chen, H., Wu, J., & Liu, C. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.05.034 · Cited by 120
“Varied subunits of NADPH oxidase are found expressed in various cell types (Drummond et al., 2011) and are inducible in certain pathologies (Ritchie et al., 2007).”
BackgroundNatural isothiocyanates: Genotoxic potential versus chemoprevention
Fimognari, C., Turrini, E., Ferruzzi, L., Lenzi, M., & Hrelia, P. (2011) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2011.12.001 · Cited by 126
“disease, and thus a target for cardiovascular prevention [69].”
BackgroundAn evaluation on potential anti-oxidant and anti-inflammatory effects of Crocin
Bastani, S., Vahedian, V., Rashidi, M., Mir, A., Mirzaei, S., Alipourfard, I., Pouremamali, F., Nejabati, H. R., Kadkhoda, J., Maroufi, N. F., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113297 · Cited by 133
NADPH Oxidase-4 Maintains Neuropathic Pain after Peripheral Nerve Injury
Kallenborn-Gerhardt, W., Schröder, K., Del Turco, D., Lu, R., Kynast, K., Kosowski, J., Niederberger, E., Shah, A. M., Brandes, R. P., Geisslinger, G., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6227-11.2012 · Cited by 113
“Given the crucial role of Nox2-derived ROS in the innate immune response to invading pathogens and the possibility that pharmacological Nox2 inhibition could severely compromise a patient’s immunological function (Drummond et al., 2011), selective Nox4 inhibitors might have therapeutic advantages over Nox2 inhibitors…”
BackgroundThe human Nox4: gene, structure, physiological function and pathological significance
Guo, S., & Chen, X. (2015) · Journal of Drug Targeting · doi:10.3109/1061186x.2015.1036276 · Cited by 113
“Nox1 and Nox2 are considered to be the major sources of ROS in the artery wall in vascular disease conditions [122].”
BackgroundSex-related differences in oxidative stress and neurodegeneration
Tenkorang, M. A., Snyder, B., & Cunningham, R. L. (2018) · Steroids · doi:10.1016/j.steroids.2017.12.010 · Cited by 113
“in the enzyme NADPH oxidase (NOX) [11,13,18–20], which is a major oxidative stress generator in cells [21].”
Xiao, L., Liu, L., Guo, X., Zhang, S., Wang, J., Zhou, F., Liu, L., Tang, Y., & Yao, P. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.03.048 · Cited by 120
Atrial Fibrillation Therapy Now and in the Future: Drugs, Biologicals, and Ablation
Woods, C. E., & Olgin, J. E. (2014) · Circulation Research · doi:10.1161/circresaha.114.302362 · Cited by 119
“phate oxidase (NOX), mitochondrial xanthine oxidase (mitochondrial), and uncoupled endothelial nitric oxide synthase.(55,56)”
Backgroundvan Golen, R. F., Reiniers, M. J., Vrisekoop, N., Zuurbier, C. J., Olthof, P. B., van Rheenen, J., van Gulik, T. M., Parsons, B. J., & Heger, M. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5751 · Cited by 125
Targeting oxidant-dependent mechanisms for the treatment of COPD and its comorbidities
Bernardo, I., Bozinovski, S., & Vlahos, R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.08.005 · Cited by 115
“It inhibits NOX by preventing the assembly of the NOX enzyme subunits, resulting in the reduced formation of NOX complexes (Selemidis et al., 2008; Drummond et al., 2011).”
BackgroundCeriello, A., Testa, R., & Genovese, S. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.01.006 · Cited by 119
“NOX1, NOX2, NOX4 and NOX5 are expressed in the endothelial cells; NOX1, NOX4 and NOX5 are expressed in the vascular smooth muscle cells; and NOX2 and NOX4 are expressed in the adventitial fibroblasts [10,20].”
BackgroundUpregulation of mitochondrial Nox4 mediates TGF-β-induced apoptosis in cultured mouse podocytes
Das, R., Xu, S., Quan, X., Nguyen, T. T., Kong, I. D., Chung, C. H., Lee, E. Y., Cha, S.-K., & Park, K.-S. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00438.2013 · Cited by 104
Oxidative stress: fundamentals and advances in quantification techniques
Krishnamurthy, H. K., Pereira, M., Rajavelu, I., Jayaraman, V., Krishna, K., Wang, T., Bei, K., & Rajasekaran, J. J. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1470458 · Cited by 141
The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation
Walsh, T. G., Berndt, M. C., Carrim, N., Cowman, J., Kenny, D. J., & Metharom, P. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.023 · Cited by 107
Phenolic Metabolites of Anthocyanins Modulate Mechanisms of Endothelial Function
Edwards, M., Czank, C., Woodward, G. M., Cassidy, A., & Kay, C. D. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf5041993 · Cited by 103
Myeloperoxidase: Growing importance in cancer pathogenesis and potential drug target
Valadez-Cosmes, P., Raftopoulou, S., Mihalič, Z. N., Marsche, G., & Kargl, J. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108052 · Cited by 113
Chen, S., Su, Y., & Wang, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.253 · Cited by 116
Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?
Silva, T. M. D., & Miller, A. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00061 · Cited by 112
“The structure and functioning of the Nox isoforms have been comprehensively Frontiers in Pharmacology | www.frontiersin.org 3 March 2016 | Volume 7 | Article 61 reviewed (Selemidis et al., 2008; Drummond et al., 2011; Lassegue et al., 2012) and thus will not be discussed here.”
BackgroundInfluentialHernanz, R., Briones, A. M., Salaíces, M., & Alonso, M. J. (2013) · Clinical Science · doi:10.1042/cs20120651 · Cited by 115
Hypertension and chronic ethanol consumption: What do we know after a century of study?
Marchi, K. C., Muniz, J. J., & Tirapelli, C. R. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i5.283 · Cited by 102
NADPH Oxidases as Regulators of Tumor Angiogenesis: Current and Emerging Concepts
Coso, S., Harrison, I., Harrison, C. B., Vinh, A., Sobey, C. G., Drummond, G. R., Williams, E. D., & Selemidis, S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4489 · Cited by 99
“Indeed, future studies will need to carefully define (1) stromal cell ( i.e. , endothelial cell)-specific and immune cell (macrophages, Tregs)-specific roles of Nox2 and other ROS generating enzymes, including Nox1, Nox4, Duox1, and Duox2; ( (lymph) angiogenic switch in different types of endothelial and cancer cells; an…”
InfluentialSelf-citationCarlstrom, M., & Montenegro, M. F. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12818 · Cited by 96
Liu, X., Ye, B., Miller, S. W., Yuan, H., Zhang, H., Liang, T., Nie, J., Imae, R., Arai, H., Li, Y., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01092-12 · Cited by 104
Targeting Mitochondria and Reactive Oxygen Species-Driven Pathogenesis in Diabetic Nephropathy
Lindblom, R., Higgins, G., Coughlan, M., & de Haan, J. B. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.134 · Cited by 98
“Since NOX isoenzymes reside within cells and span membranes of cells [53], it is likely that NOX4 spans the inner membrane of mitochondria, and that O2 •- or H2O2 are released into the intermembrane space (IMS) of mitochondria.”
BackgroundReactive Oxygen Species in Pathogenesis of Atherosclerosis
Goncharov, N., Avdonin, P., Nadeev, A., Zharkikh, I., & Jenkins, R. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612820666141014142557 · Cited by 97
“The principal difference between NOX and other sources of ROS is that for the former the generation of ROS is their major function [22].”
BackgroundThe opposing roles of NO and oxidative stress in cardiovascular disease
Ritchie, R. H., Drummond, G. R., Sobey, C. G., Silva, T. M. D., & Kemp‐Harper, B. K. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.017 · Cited by 109
Self-citationThe Future Challenge of Reactive Oxygen Species (ROS) in Hypertension: From Bench to Bed Side
Togliatto, G., Lombardo, G., & Brizzi, M. F. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091988 · Cited by 104
“Progress in the search for the best Nox inhibitors has been made [152].”
BackgroundDevelopment of calcific aortic valve disease: Do we know enough for new clinical trials?
Kostyunin, A. E., Yuzhalin, A. E., Ovcharenko, E. A., & Kutikhin, A. G. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.05.016 · Cited by 95
Pinz, M. P., dos Reis, A. S., Duarte, V., da Rocha, M. J., Goldani, B. S., Alves, D. A. C., Savegnago, L., Luchese, C., & Wilhelm, E. A. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.03.039 · Cited by 95
“TNF-α and IL-1B activate NADPH oxidase inducing the production of superoxide anion, starting the generation of reactive oxygen species (Drummond et al., 2011).”
BackgroundBrassington, K., Selemidis, S., Bozinovski, S., & Vlahos, R. (2019) · Clinical Science · doi:10.1042/cs20180316 · Cited by 111
Self-citationOostwoud, L. C., Gunasinghe, P., Seow, H. J., Ye, J. M., Selemidis, S., Bozinovski, S., & Vlahos, R. (2016) · Scientific Reports · doi:10.1038/srep20983 · Cited by 90
Self-citationMartinelli, R., Kamei, M., Sage, P. T., Massol, R., Varghese, L., Sciuto, T. E., Toporsian, M., Dvořàk, A. M., Kirchhausen, T. L., Springer, T. A., et al. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201209077 · Cited by 97
“…excessive ROS production are generally viewed as harmful to tissues (Griendling et al., 2000; Lum and Roebuck, 2001; Rodrigues and Granger, 2010; Drummond et al., 2011; Browning et al., 2012), our studies define a specific protective/ homeostatic role for ROS in the maintenance of tissue…”
InfluentialCerebral Small Vessel Disease (CSVD) – Lessons From the Animal Models
Mustapha, M., Nassir, C. M. N. C. M., Aminuddin, N., Safri, A. A., & Ghazali, M. M. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01317 · Cited by 103
NOXious signaling in pain processing
Kallenborn-Gerhardt, W., Schröder, K., Geißlinger, G., & Schmidtko, A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.001 · Cited by 100
NADPH Oxidase 4 Mediates Insulin-Stimulated HIF-1α and VEGF Expression, and Angiogenesis In Vitro
Meng, D., Mei, A., Liu, J., Kang, X., Shi, X., Qian, R., & Chen, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048393 · Cited by 91
“Noxfamily NADPH oxidases have proven to be a major source of ROS production in various cell types and have crucial roles in various physiological and pathological processes [11–14].”
New Insight into the Role of Reactive Oxygen Species (ROS) in Cellular Signal-Transduction Processes
Russell, E. G., & Cotter, T. G. (2015) · International review of cytology · doi:10.1016/bs.ircmb.2015.07.004 · Cited by 107
Seo, K., Yang, J. H., Kim, S. C., Ku, S. K., Ki, S. H., & Shin, S. M. (2014) · Inflammation · doi:10.1007/s10753-013-9789-6 · Cited by 90
H2O2 Metabolism in Normal Thyroid Cells and in Thyroid Tumorigenesis: Focus on NADPH Oxidases
Szántó, I., Pusztaszeri, M. P., & Mavromati, M. (2019) · Antioxidants · doi:10.3390/antiox8050126 · Cited by 104
Engineering Fe–N Doped Graphene to Mimic Biological Functions of NADPH Oxidase in Cells
Wu, D., Li, J., Xu, S., Xie, Q., Pan, Y., Liu, X., Ma, R., Zheng, H., Gao, M., Wang, W., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c08360 · Cited by 89
Oxidative Stress and Arterial Dysfunction in Peripheral Artery Disease
Ismaeel, A., Brumberg, R. S., Kirk, J. S., Papoutsi, E., Farmer, P. J., Bohannon, W. T., SMITH, R. S., Eidson, J. L., Sawicki, I., & Koutakis, P. (2018) · Antioxidants · doi:10.3390/antiox7100145 · Cited by 97
“Historically, only underactive NOX systems were of interest, as this leads to the rare condition known as chronic granulomatous disease, in which the ability of leukocytes to produce ROS is impaired, which causes a greater susceptibility to microbial infections [24].”
BackgroundInfluentialMediterranean diet and cognitive function: From methodology to mechanisms of action
Siervo, M., Shannon, O. M., Llewellyn, D. J., Stephan, B. C., & Fontana, L. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.09.018 · Cited by 86
The Quest for Selective Nox Inhibitors and Therapeutics: Challenges, Triumphs and Pitfalls
Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5620 · Cited by 84
“Many reviews have been dedicated to describing the available Nox inhibitors in recent years (29, 48, 78, 85, 89) and since then relatively few new compounds have come to the forefront.”
BackgroundWijnker, P. J. M., Sequeira, V., Kuster, D. W. D., & van der Velden, J. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7236 · Cited by 108
Are reactive oxygen species still the basis for diabetic complications?
Marco, E. D., Jha, J. C., Sharma, A., Wilkinson-Berka, J. L., Jandeleit-Dahm, K. A., & de Haan, J. B. (2015) · Clinical Science · doi:10.1042/cs20150093 · Cited by 86
Mechanisms underlying blood pressure reduction by dietary inorganic nitrate
Carlström, M., Lundberg, J. O., & Weitzberg, E. (2018) · Acta Physiologica · doi:10.1111/apha.13080 · Cited by 86
Ciofani, G., Genchi, G. G., Mazzolai, B., & Mattoli, V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.009 · Cited by 87
“It is particularly studied in thefield of vascular research, because of its role in vascular oxidative stress andhypertension [57,58].”
Natural products: The role and mechanism in low‐density lipoprotein oxidation and atherosclerosis
Zhang, S., Li, L., Chen, W., Xu, S., Feng, X., & Zhang, L. (2020) · Phytotherapy Research · doi:10.1002/ptr.7002 · Cited by 108
Architecture of the NADPH oxidase family of enzymes
Ogboo, B. C., Grabovyy, U. V., Maini, A., Scouten, S., van der Vliet, A., Mattevi, A., & Heppner, D. E. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102298 · Cited by 92
Skibska, B., & Gorąca, A. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/313021 · Cited by 97
Healthy lifestyle-based approaches for successful vascular aging
Rossman, M. J., LaRocca, T. J., Martens, C. R., & Seals, D. R. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00521.2018 · Cited by 82
The multifaceted role of ischemia/reperfusion in sickle cell anemia
Hebbel, R. P., Belcher, J. D., & Vercellotti, G. M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci133639 · Cited by 88
Subramanian, U., Gopi, V., & Vellaichamy, E. (2013) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2013.11.013 · Cited by 83
Nontypeable Haemophilus influenzae Induces Sustained Lung Oxidative Stress and Protease Expression
King, P. T., Sharma, R., O’Sullivan, K. M., Selemidis, S., Lim, S. C. L., Radhakrishna, N., Lo, C. Y.-W., Prasad, J. D., Callaghan, J. M., McLaughlin, P. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120371 · Cited by 82
Self-citationLillioja, S., Neal, A. L., Tapsell, L., & Jacobs, D. R. (2013) · BioFactors · doi:10.1002/biof.1077 · Cited by 82
“The plasma concentrations of vitamin E ( 30 lM) or vitamin C ( 37 lM) [172,173] are at least an order of magnitude lower than glutathione, and glutathione is just one of the many anti-oxidant peptides defending against ROS [148,149,158].”
BackgroundInfluentialLiu, F., Fang, S., Liu, X., Li, J., Wang, X., Cui, J., Chen, T., Li, Z., Yang, F., Tian, J., et al. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113830 · Cited by 85
Reactive Oxygen Species and Oxidative Stress in Vascular‐Related Diseases
Cheng, X., Hu, Y., Yang, T., Wu, N., & Wang, X.-N. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7906091 · Cited by 94
“Of these, NOX1 and NOX4 are present in VSMCs, while NOX2 and NOX4 are primarily expressed in ECs [21].”
Redox-inflammatory synergy in the metabolic syndrome
Bryan, S., Baregzay, B., Spicer, D., Singal, P. K., & Khaper, N. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0295 · Cited by 80
“Activation of NOX, and particularly the NOX1 and NOX2 isoforms, results in increased O2 production, which damages vascular tissues, impairs relaxation owing to NO inactivation, and promotes ONOO− formation (Rabkin 2009; Khaper et al. 2010; Drummond et al. 2011).”
BackgroundInfluentialMicrovascular NADPH oxidase in health and disease
Li, Y., & Pagano, P. J. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.02.049 · Cited by 80
“At the level of microcirculation, endothelial dysfunction is believed to play a key role in the development of atherosclerosis, abnormal angiogenesis, vascular leakage and stroke, all of which are associated with enhanced oxidative stress [110].”
Yang, J., Wang, T., Yang, J., Rao, K., Zhan, Y., Chen, R., Liu, Z., Li, M. ‐., Zhuan, L., Zang, G., et al. (2013) · Andrology · doi:10.1111/j.2047-2927.2012.00060.x · Cited by 79
“It was recently postulated that the potency of conventional antioxidants is limited because they can only remove particular ROS in a stoichiometric manner and may produce other types of ROS, which are the oxidized forms of the parent molecules (Drummond et al., 2011).”
BackgroundInfluentialRole of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brain
Chrissobolis, S., Banfi, B., Sobey, C. G., & Faraci, F. M. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00455.2012 · Cited by 78
Self-citationDe Silva, T. M., Brait, V. H., Drummond, G. R., Sobey, C. G., & Miller, A. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028393 · Cited by 78
“Nox2-, and Nox4-containing NADPH oxidases (or ‘Nox oxidases’) [12,13].”
BackgroundInfluentialSelf-citationAghamohammadzadeh, R., & Heagerty, A. M. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.663928 · Cited by 89
“It has been recently proposed that prevention of ROS generation using NADPH oxidase (NOX1 and NOX2) inhibitors may be a better way of tackling the oxidative stress problem rather than attempting to scavenge the free radicals once they have been generated (94).”
BackgroundObligatory role for GPER in cardiovascular aging and disease
Meyer, M. R., Fredette, N. C., Daniel, C., Sharma, G., Amann, K., Arterburn, J. B., Barton, M., & Prossnitz, E. R. (2016) · Science Signaling · doi:10.1126/scisignal.aag0240 · Cited by 87
Sun, Q.-A., Hess, D. T., Wang, B., Miyagi, M., & Stamler, J. S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.046 · Cited by 76
“enzymatic (and non-enzymatic) sources [6].”
Shafique, E., Choy, W. C., Liu, Y., Feng, J., Cordeiro, B., Lyra, A., Arafah, M., Yassin-Kassab, A., Zanetti, A. V. D., Clements, R. T., et al. (2013) · Aging · doi:10.18632/aging.100569 · Cited by 76
Liong, S., Oseghale, O., To, E. E., Brassington, K., Erlich, J. R., Luong, R., Liong, F., Brooks, R. D., Martin, C. M., O’Toole, S. A., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006905117 · Cited by 76
Self-citationMaiocchi, S. L., Ku, J., Thai, T., Chan, E., Rees, M. D., & Thomas, S. R. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107711 · Cited by 82
To, E. E., Broughton, B. R. S., Hendricks, K. S., Vlahos, R., & Selemidis, S. (2014) · Free Radical Research · doi:10.3109/10715762.2014.927579 · Cited by 75
Self-citation
Metadata
- Authors
- Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G.
- Affiliations
- Monash University (AU)
- Emory University (US)
- Corresponding author
- Drummond, Grant R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2011-06
- Volume
- 10
- Issue
- 6
- Pages
- 453-471
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3361719
- OpenAlex
- W1974997758
- Cited by
- 899
- References
- 237
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 38 · 2023: 35 · 2022: 51 · 2021: 66 · 2020: 69 · 2019: 55 · 2018: 63 · 2017: 77 · 2016: 69 · 2015: 71 · 2014: 83 · 2013: 88 · 2012: 71
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RMIT Research Repository (RMIT University Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (HL38206, R01HL038206, HL095070, HL058863, R37HL038206, HL-092120, R01HL092120, P01HL095070, R01HL058863)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- NADPH oxidase, NOX1, NOX2, oxidative stress, reactive oxygen species, NADPH oxidase inhibitors, p47phox, endothelial dysfunction, vascular inflammation, atherogenesis, arterial remodeling, hypertension, hypercholesterolemia, diabetes mellitus, aging, cardiovascular disease
- MeSH terms
- NADPH Oxidase 1, NADPH Oxidase 2, Animals, Antioxidants, Humans, Membrane Glycoproteins, NADH, NADPH Oxidoreductases, Vascular Diseases, Drug Delivery Systems, Reactive Oxygen Species, Oxidative Stress, NADPH Oxidases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.